Screening Donated Blood and Plasma for HTLV-III Antibody: Facing More Than One Crisis?

Michael T Osterholm, Robert J. Bowman, Michael W. Chopek, Jeffrey Mc Cullough, Jack A. Korlath, Herbert F. Polesky

Research output: Contribution to journalEditorial

29 Scopus citations

Abstract

Little question remains that the causative agent of the acquired immunodeficiency syndrome (AIDS) is the newly recognized retrovirus, human T-cell lymphotropic virus Type III (HTLV-III).1 2 3 4 5 AIDS, the AIDS-related complex, and asymptomatic HTLV-III infection have been associated with several well-defined high-risk groups, including recipients of blood and blood products.6 7 8 Protection of our nation's blood and plasma supply from HTLV-III contamination has been one of the highest public health priorities related to the AIDS epidemic. Studies of symptomatic and asymptomatic members of high-risk groups indicate that those who are infected with HTLV-III are also likely to be positive for HTLV-III antibody.3,9 10 11 Tests.

Original languageEnglish (US)
Pages (from-to)1185-1189
Number of pages5
JournalNew England Journal of Medicine
Volume312
Issue number18
DOIs
StatePublished - May 2 1985

Fingerprint Dive into the research topics of 'Screening Donated Blood and Plasma for HTLV-III Antibody: Facing More Than One Crisis?'. Together they form a unique fingerprint.

  • Cite this